FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2334084901> ?p ?o ?g. }

• W2334084901 endingPage "1649" @default.
• W2334084901 startingPage "1649" @default.
• W2334084901 abstract "Purpose: We compared changes of plasma angiogenesis cytokine profiles in infants who were treated with intravitreal injection of bevacizumab (IVB) for type 1 retinopathy of prematurity (ROP) with age-matched preterm non-ROP infants. Methods: Thirteen infants with type 1 ROP and 13 age-matched preterm non-ROP infants were included. Blood samples were collected prior to treatment (time 0) and 6 weeks after the treatment (time 42). Plasma levels of nine cytokines from the angiogenesis growth factor panel and seven soluble cytokine receptors were measured using a magnetic multiplex assay. Results: Plasma cytokine profiles changed from time 0 to time 42 in both groups. In bevacizumab-treated ROP infants, the following plasma angiogenesis growth factor and soluble cytokine receptor levels decreased significantly: soluble VEGF-A (sVEGF-A; P = 0.0001), sVEGF-D (P = 0.04), angiopoietin-2 (Ang-2; P = 0.002), sVEGF receptor 1 (R1) and R2 (P = 0.005), soluble IL-6 receptor (sIL-6R; P = 0.002), soluble glycoprotein 130 (spg130; P = 0.0001), and soluble TNF receptor (sTNFR) I and II (P = 0.0001). The following factors and receptors increased significantly: sVEGF-C (P = 0.05), placental growth factor (PlGF; P = 0.02), endothelin-1 (ET-1; P = 0.0001), and FGF-1 (P = 0.02). At time 42, sVEGF-A, sgp130, sIL-6R, sTNFR I, and sTNFR II were lower, and ET-1 level was higher, in bevacizumab-treated ROP infants compared to age-matched non-ROP infants. Conclusions: The results suggest that bevacizumab treatment resulted in significant angiogenic cytokine profile changes in infants with severe ROP. The long-term clinical impact of these changes should be studied carefully." @default.
• W2334084901 created "2016-06-24" @default.
• W2334084901 creator A5005183262 @default.
• W2334084901 creator A5011782005 @default.
• W2334084901 creator A5015905027 @default.
• W2334084901 creator A5051272739 @default.
• W2334084901 creator A5056188954 @default.
• W2334084901 date "2016-04-07" @default.
• W2334084901 modified "2023-09-25" @default.
• W2334084901 title "Assessment of Plasma Cytokine Profile Changes in Bevacizumab-Treated Retinopathy of Prematurity Infants" @default.
• W2334084901 cites W1489873347 @default.
• W2334084901 cites W1587020653 @default.
• W2334084901 cites W1603758502 @default.
• W2334084901 cites W1969356938 @default.
• W2334084901 cites W1975535670 @default.
• W2334084901 cites W1982008460 @default.
• W2334084901 cites W1990653694 @default.
• W2334084901 cites W1999841046 @default.
• W2334084901 cites W2000099545 @default.
• W2334084901 cites W2013141629 @default.
• W2334084901 cites W2014434817 @default.
• W2334084901 cites W2027616862 @default.
• W2334084901 cites W2029557435 @default.
• W2334084901 cites W2048300556 @default.
• W2334084901 cites W2048818094 @default.
• W2334084901 cites W2062049280 @default.
• W2334084901 cites W2077903003 @default.
• W2334084901 cites W2080435120 @default.
• W2334084901 cites W2083440154 @default.
• W2334084901 cites W2107919129 @default.
• W2334084901 cites W2113170046 @default.
• W2334084901 cites W2117159126 @default.
• W2334084901 cites W2132863873 @default.
• W2334084901 cites W2164569629 @default.
• W2334084901 cites W2166573361 @default.
• W2334084901 cites W2334508015 @default.
• W2334084901 cites W2341635912 @default.
• W2334084901 cites W2994100827 @default.
• W2334084901 cites W32167704 @default.
• W2334084901 doi "https://doi.org/10.1167/iovs.15-18528" @default.
• W2334084901 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27054517" @default.
• W2334084901 hasPublicationYear "2016" @default.
• W2334084901 type Work @default.
• W2334084901 sameAs 2334084901 @default.
• W2334084901 citedByCount "8" @default.
• W2334084901 countsByYear W23340849012016 @default.
• W2334084901 countsByYear W23340849012017 @default.
• W2334084901 countsByYear W23340849012018 @default.
• W2334084901 countsByYear W23340849012020 @default.
• W2334084901 countsByYear W23340849012021 @default.
• W2334084901 crossrefType "journal-article" @default.
• W2334084901 hasAuthorship W2334084901A5005183262 @default.
• W2334084901 hasAuthorship W2334084901A5011782005 @default.
• W2334084901 hasAuthorship W2334084901A5015905027 @default.
• W2334084901 hasAuthorship W2334084901A5051272739 @default.
• W2334084901 hasAuthorship W2334084901A5056188954 @default.
• W2334084901 hasBestOaLocation W23340849011 @default.
• W2334084901 hasConcept C126322002 @default.
• W2334084901 hasConcept C134018914 @default.
• W2334084901 hasConcept C167734588 @default.
• W2334084901 hasConcept C170493617 @default.
• W2334084901 hasConcept C2776694085 @default.
• W2334084901 hasConcept C2776871010 @default.
• W2334084901 hasConcept C2777025900 @default.
• W2334084901 hasConcept C2777802072 @default.
• W2334084901 hasConcept C2778376644 @default.
• W2334084901 hasConcept C2778690821 @default.
• W2334084901 hasConcept C2779234561 @default.
• W2334084901 hasConcept C2779918416 @default.
• W2334084901 hasConcept C2780394083 @default.
• W2334084901 hasConcept C54355233 @default.
• W2334084901 hasConcept C71924100 @default.
• W2334084901 hasConcept C86803240 @default.
• W2334084901 hasConceptScore W2334084901C126322002 @default.
• W2334084901 hasConceptScore W2334084901C134018914 @default.
• W2334084901 hasConceptScore W2334084901C167734588 @default.
• W2334084901 hasConceptScore W2334084901C170493617 @default.
• W2334084901 hasConceptScore W2334084901C2776694085 @default.
• W2334084901 hasConceptScore W2334084901C2776871010 @default.
• W2334084901 hasConceptScore W2334084901C2777025900 @default.
• W2334084901 hasConceptScore W2334084901C2777802072 @default.
• W2334084901 hasConceptScore W2334084901C2778376644 @default.
• W2334084901 hasConceptScore W2334084901C2778690821 @default.
• W2334084901 hasConceptScore W2334084901C2779234561 @default.
• W2334084901 hasConceptScore W2334084901C2779918416 @default.
• W2334084901 hasConceptScore W2334084901C2780394083 @default.
• W2334084901 hasConceptScore W2334084901C54355233 @default.
• W2334084901 hasConceptScore W2334084901C71924100 @default.
• W2334084901 hasConceptScore W2334084901C86803240 @default.
• W2334084901 hasIssue "4" @default.
• W2334084901 hasLocation W23340849011 @default.
• W2334084901 hasLocation W23340849012 @default.
• W2334084901 hasOpenAccess W2334084901 @default.
• W2334084901 hasPrimaryLocation W23340849011 @default.
• W2334084901 hasRelatedWork W1996846474 @default.
• W2334084901 hasRelatedWork W1999442509 @default.
• W2334084901 hasRelatedWork W2018368842 @default.
• W2334084901 hasRelatedWork W2033472167 @default.

• next